News
The drug receives conditional marketing authorization by the CHMP for the treatment of HER2-positive biliary tract cancer.
Nasdaq files a 19b-4 form with the US Securities & Exchange Commission (SEC) on Tuesday to list the 21Shares Dogecoin (DOGE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback